Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Integral Molecular Secures $8 Million NIAID Contract to Combat Emerging Viruses

Oct 23, 2024•over 1 year ago

Contract Type

contract

PhiladelphiaBiotechnology

Description

Integral Molecular has secured a five-year, $8 million contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). This funding will support the company's ongoing research into emerging viruses identified as pandemic threats.

Company Information

Company

Integral Molecular

Location

Philadelphia, Pennsylvania, United States

About

Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, and transporters. The Company has over a decade of experience in optimizing membrane proteins, enabling the isolation, characterization, and engineering of monoclonal antibodies against otherwise intractable membrane protein targets. Its customers include all of the top pharmaceutical and biotechnology companies.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Integral Molecular's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months